Regarding disease activity, the median DAS28-CRP during the study was 2.5 (IQR 2.0-2.9) in the RA patients and the median BASDAI was 4.1 (IQR 2.3–6.4) in the SpA patients. The gene discussed is CRP; the disease is rheumatoid arthritis.